{"name":"Accelerate Diagnostics Inc.","slug":"accelerate-dx","ticker":"AXDX","exchange":"NASDAQ","domain":"acceleratediagnostics.com","description":"Accelerate Diagnostics Inc. (AXDX) is a company focused on developing and commercializing innovative diagnostic solutions for infectious diseases. The company's key products include its Accelerate Pheno system, which provides rapid and accurate identification of bacterial pathogens. With a strong presence in the diagnostics market, AXDX aims to improve patient outcomes and reduce healthcare costs. The company's products are used in hospitals and laboratories worldwide.","hq":"Tucson, AZ","founded":2010,"employees":"~100","ceo":"Jack Phillips","sector":"Diagnostics / Infectious Disease","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$1.3B","metrics":{"revenue":10000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"Accelerate Diagnostics Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Accelerate Diagnostics reported its fourth quarter and full year 2023 financial results, with revenue of $14.4 million and a net loss of $24.5 million.","drugName":"","sentiment":"neutral"},{"date":"2023-11-15","type":"deal","headline":"Accelerate Diagnostics Announces Collaboration with the National Institutes of Health (NIH)","summary":"Accelerate Diagnostics announced a collaboration with the National Institutes of Health (NIH) to develop and commercialize its diagnostic solutions for infectious diseases.","drugName":"","sentiment":"positive"},{"date":"2023-08-01","type":"regulatory","headline":"Accelerate Diagnostics Receives FDA Clearance for PhenoTest BC-GN","summary":"Accelerate Diagnostics received FDA clearance for its PhenoTest BC-GN system, which provides rapid and accurate identification of bacterial pathogens.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNNmlHMTdSY0ppQmNDeDEyT2hUd2JYbmt1b09mZ0dYdE5uaXBRX2x3R0Q5UzhDQm45UzJCQnJwT3BLSGRMdVVyNV9hTm9VLUFRVHM0T21ETDNkMVhqYnJBczZOaHByT1FzWFZyTG85elpUeVJSNzRpSWY4X0tqNC1XNHdMa1ZkX1A1bWdvNUg2QkxyT0Y3b2dOczhXRy1fNi00Qm5fNGd4ZXctSGpPSk9XYzVuR3FBall1akY2aHlabEI?oc=5","date":"2025-05-08","type":"pipeline","source":"Stock Titan","summary":"Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets - Stock Titan","headline":"Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxPMHMtaVZTOXNyN211LWhTc2tiaGUzUWlITkE4eUZuVDQtaUozUmlxaWg3aGV5QVNxem5Ga2wyMnYxUE9ZVUpRdWY2LWRaRmNLclh2V2Z4WXpFNUY2cVpwVm9JeGxUTlpTeUNRdE9ubTBTRmF2SEpuQ0RjdXRwSGprWDQyZHcyVTRjbE9SWTlmVExpNkJEcXU4dGtOWmNJLTNHYXlLLXRvRjIyNzdaaTByN2hVNEdCVXE5QzZtSWVEalFiR3VvSUVwMXJhODNUOEk3UUtZNFA5NHg1TWEwZWR1SEFLYWM4MWZKZHpTa1JHTUxjeDlSQXc?oc=5","date":"2025-05-08","type":"pipeline","source":"PR Newswire","summary":"Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets - PR Newswire","headline":"Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNaUJrVkt0czhqaEpTSldGdVJvMUQ2U3kzcTBpbkpHMnlyMFpRV2FiX21rMVd1enpUVW5qUmNvbEctVGNYX1hoZW8tTV9ENUY5VGxqRFQtX3RuUzh1M3JxeUZpbEZ1OEdZZmxfQnpOaEtMWVQzUnhBYlQwWW9lOGlFQi1Rbm1ycDhaeFZ2ci16eEhxWEd6WDVnSzRZSG9sRmZfdEpoSFdxc0JObmdaT2lhMnVVZnhwSFB5ci1ZcUFGcFhlbDBHWkEzc0I0Szdtclk4NWd4Wg?oc=5","date":"2025-03-21","type":"earnings","source":"PR Newswire","summary":"Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results - PR Newswire","headline":"Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxQS1lJMC04WHRtR1lUa3pFSnNVS3V3WVNZaGdscEJkVzAxOGhlQ1paQlNBb2ZPYm52WFlZcXBuZVU4YWFwYmhxR0FETXA3MUxGMTZnTzE1emZSSHFSVFVSaEcxS1JqaFFhdXhseXZaMUdBUVBvT3RaMnRJMlFXTU1oellsRjFEOHphY0tjb0hlTGVHREhrMzRyMTdrQjFBdzRpenRqdTNDdWNyTlpWMDI1OWw3ZVNoM19xS21xdHJSUTVTc2puelAzbWp4TG16d0Y0QW5ubC1tVzZ4bUtKX2RuRG9uZ2c?oc=5","date":"2025-01-10","type":"earnings","source":"PR Newswire","summary":"Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results - PR Newswire","headline":"Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPVkJyM25LdDRuNEQzY2c0MGNDQjZYdjZReFh1REhiUloyZ1JpM2dpeFN5Q0t4RGhwQjctcUpvVkI4eExxZF9aTmc2TlRTWHd2WEEtbTJ6YS1iUW9wTmlKUHp5dzBGd1g2RGJ4dzM4V2w1cUZFd0kzczV1TzFxX1FSckE4LXhBSHN3QWJSNjNqUmFuTDVoMlQwbWxhVDZhUEJtclBBODFTYTVZbDdaZ3pBMzBiTXQtd0hOT01mb2JwcEg0WGpQQ2NmUVRHMA?oc=5","date":"2024-09-30","type":"regulatory","source":"PR Newswire","summary":"Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System - PR Newswire","headline":"Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxPRzlMSThUYlJTU1E1VHZiSFJJcnJ0VmM2UzF3eFVJUmctN3Q0X1VqVk9odXZXdG5OUXlDNFh1NHBWbS1JbG1LRmlWVlhUV3FhMVp2QXlrc0RCWm5kajEyS2hKMGowcHlwd2Z5ME1BZlNxVVpkcjZPTHNWOGhad2lTMmlMaXZwWktkSTJCSW5vdVJwRGt1NHlva2lGMUJpTFdES0xpbFFpbWFxdlh0YjhCQWdScS0zTnNKVkNsVWxrWFllYjMyV3JOa1E5RHRMam5YZEZzOV9UOHNzcnM?oc=5","date":"2024-08-08","type":"trial","source":"PR Newswire","summary":"Accelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical Trial - PR Newswire","headline":"Accelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical Trial","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirwJBVV95cUxPTHhYakpiMzdyZGRreWxkOVdOWkN1cjNmaHhEcWc1cDZFMVBUS1huc0k4dnFTLWtTZ2VtMlotbUtWbms3YjVSWmRiZ2IxNk04elNrYW5LNlA1WGZKNExlc0ZKZ0lwaG44YnhmcnhCUUc4bzU2cHlGaFdDYTZ6NHVKSmNhbjhkaGIwSFJXcVlSUm44Yno3NVJtNDNCcmNyeHNUQkhnaUd1dmFCc1lhZkw3OEtpeVQySndEY3EzN25zUjVWZlMwanFtQ19kb29DelZUM29BekNma05UWTJhN3V6WnoyYU5JRmtYSjhnaGN1MkhaTGRORFgzSnByNWtvRC1TSFRnU1hMbGJ5R3ZVMnFjUzRoMzZpOU9WTzhFWDVpV2lHdmRGUFJaS3VScTQ0Njg?oc=5","date":"2023-06-13","type":"pipeline","source":"PR Newswire","summary":"Accelerate Diagnostics Announces Successful Completion of Debt Restructuring Support Agreement, Supporting Advancement of Next-Generation Platform Wave - PR Newswire","headline":"Accelerate Diagnostics Announces Successful Completion of Debt Restructuring Support Agreement, Supporting Advancement o","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxNckNydDdMM0tXSmYyTHk3ZkNRVnF3QkxoUHRxNGl2R2M5a1NxZmJXUkRIMV9zYXpqNG92NUJrLWhhZGdJZFVkRVdQUkhVZ3dadVdkVlNhYTFHMWZhNy1HWXhtakIwV0pBdHJycVNjODZhWTNNaGNsUUdfVWRNRUUxZUhpSVg4M0R1ckZqeWc0dUNVX3NoM2EwZVNLT05qbDY1QTV4a3cxRDgxQ0JLN2gyQU1yWVVLWXE4a09CZVpNeUpCNEo1QkRXU3JVeU1jd29IWmZpZTh3WlpXWTNaYW9pTElnLUJlRFRqb01ELS11enlJbDd3Y2IxbE1UUENjZmM?oc=5","date":"2023-03-14","type":"pipeline","source":"PR Newswire","summary":"Accelerate Diagnostics announces departure of CFO Steve Reichling and appointment of David Patience as replacement - PR Newswire","headline":"Accelerate Diagnostics announces departure of CFO Steve Reichling and appointment of David Patience as replacement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxPWVNQdURVV3FQbHo4UXVwd3R5dUtnNzMydnZZMDlzZEZnb2VzTDdTY2tIanZ3ZmtTRktYeWNuUnRxb2RqeFA5OWJpRmFSakJwWS1lY3hoZS1KZTRSNFlnbUFDOTM0VjBnYTBsZ1F5anc0YjZZYlpuS1RhQmNJZzdyR0YzU2l6eDVUYm02WnZfcnp4UFpzSEp1Nk1jSHo2bUxEb0NYRkVVQzhOclA1QTNNMEVMTnJPc1JlaFpKUmcycHhIMnRkM1FscDh1cE1RRVBtM1ZPX2lNbU1BRU1QcFB1T25KaVp6RWVkTnlGQVpBS2Y?oc=5","date":"2022-05-16","type":"earnings","source":"Investing.com UK","summary":"The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More - Investing.com UK","headline":"The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPcXBOZVR6MG5tOHNIRVlnQ2cyeEw1d2hUZXFkc1VBVnM1aEx6c25NQ0ZPM0c2R2VYZW9OMThxekUtTV9qV1BtUmJaY1BnMlMtUGdsRWo4TDVsQ0hBeUk2VEZFaVlxMzhxem14VUloa2RIUndMRV85WUF3dUc4aERNSHY5dnYwMHh4c2ZUaHU5Zw?oc=5","date":"2019-09-24","type":"pipeline","source":"PennyStocks.com","summary":"8 Penny Stocks That Became Billion Dollar Companies - PennyStocks.com","headline":"8 Penny Stocks That Became Billion Dollar Companies","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["BioMérieux","Becton Dickinson and Company","Thermo Fisher Scientific Inc."],"therapeuticFocus":["Infectious Disease"],"financials":null,"yahoo":null}